Saba S. Shaikh

Oncology
7979 Wurzbach Rd
San Antonio, TX 78229

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Spatial Transcriptomics Reveals CXCL12 + Fibroblasts as Central Immune Organizers through CXCR4 Signaling in Abdominal Aortic Aneurysm.

Spatial Transcriptomics Reveals CXCL12 + Fibroblasts as Central Immune Organizers through CXCR4 Signaling in Abdominal Aortic Aneurysm.

Journal: bioRxiv : the preprint server for biology
Published: December 08, 2025

Commensal-myeloid crosstalk in neonatal skin regulates interleukin-1 signaling and cutaneous type 17 inflammation.

Commensal-myeloid crosstalk in neonatal skin regulates interleukin-1 signaling and cutaneous type 17 inflammation.

Journal: Immunity
Published: January 09, 2025

Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Journal: JCO oncology practice
Published: October 01, 2024

Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.

Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.

Journal: Clinical breast cancer
Published: May 26, 2024

Commensal myeloid crosstalk in neonatal skin regulates cutaneous type 17 inflammation.

Commensal myeloid crosstalk in neonatal skin regulates cutaneous type 17 inflammation.

Journal: bioRxiv : the preprint server for biology
Published: October 24, 2023

Proinflammatory immune cells disrupt angiogenesis and promote germinal matrix hemorrhage in prenatal human brain.

Proinflammatory immune cells disrupt angiogenesis and promote germinal matrix hemorrhage in prenatal human brain.

Journal: Nature neuroscience
Published: September 09, 2023

Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?

Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?

Journal: Cancer
Published: July 17, 2023

Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.

Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.

Journal: JAMA dermatology
Published: March 15, 2023

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.

Journal: Frontiers in oncology
Published: August 18, 2022

A retrospective analysis of the impact of the COVID-19 pandemic on staging at presentation of patients with invasive melanoma.

A retrospective analysis of the impact of the COVID-19 pandemic on staging at presentation of patients with invasive melanoma.

Journal: Journal of the American Academy of Dermatology
Published: November 30, 2021

Second Episode of Fever as a Sentinel Event in COVID 19 a Retrospective and Prospective Observational Study.

Second Episode of Fever as a Sentinel Event in COVID 19 a Retrospective and Prospective Observational Study.

Journal: The Journal of the Association of Physicians of India
Published: August 25, 2021

Current and emerging biologic therapies for triple negative breast cancer.

Current and emerging biologic therapies for triple negative breast cancer.

Journal: Expert opinion on biological therapy
Published: July 28, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026